Kebebew Electron, Siperstein Allan E, Clark Orlo H, Duh Quan-Yang
Department of Surgery, University of California, San Francisco 94121, USA.
Arch Surg. 2002 Aug;137(8):948-51; discussion 952-3. doi: 10.1001/archsurg.137.8.948.
Laparoscopic resection for malignant adrenal tumors is controversial, because they are rare and limited data exist in the literature.
Laparoscopic adrenalectomy for malignant adrenal tumors is safe and effective.
Twenty-three patients who had a laparoscopic approach for suspected and unsuspected malignant adrenal tumors were studied retrospectively. The adrenal mass was suspected to be metastatic if the patient had a history of previous extra-adrenal primary malignancy and/or positive fine-needle aspiration cytologic findings. A primary adrenal cancer was suspected if there were positive fine-needle aspiration cytologic findings and/or a malignant adrenal imaging phenotype.
(1) Margins of tumor resection, (2) tumor recurrence (locoregional, port site, and distant), and (3) disease-free survival.
Twenty-three patients (15 men and 8 women) had 24 laparoscopic procedures (20 adrenalectomies, 3 biopsies, and 1 diagnostic laparoscopy). Permanent histologic specimens in the 23 patients showed 5 adrenocortical cancers, 1 undifferentiated adrenal cancer, 13 adrenal metastases, 2 lymphomas, and 2 cases with no evidence of tumor. Clinically suspected adrenal metastases were true positive in 19 patients (83%). The sensitivity of fine-needle aspiration cytology was 57% (n = 7). Only 1 of 6 patients with primary adrenal cancer was suspected to have a malignant tumor preoperatively. The tumor resection margin was negative in all adrenalectomies. There were 3 locoregional recurrences (2 local and 1 lymph node metastasis) in the 6 patients with primary adrenal cancer, no port site recurrences, and 4 distant recurrences in 13 patients with metastatic adrenal tumors. The disease-free survival was 65% at a mean follow-up time of 3.3 years (range, 1-7 years).
A laparoscopic approach in patients with suspected adrenal metastasis can be both diagnostic and therapeutic, and achieves complete tumor resection. In contrast, laparoscopic adrenalectomy for clinically unsuspected adrenocortical cancer is associated with a high recurrence rate. Furthermore, preoperative fine-needle aspiration cytology for the evaluation of suspected malignant adrenal tumors is unreliable.
腹腔镜切除恶性肾上腺肿瘤存在争议,因为此类肿瘤罕见且文献中的数据有限。
腹腔镜肾上腺切除术治疗恶性肾上腺肿瘤安全有效。
对23例采用腹腔镜手术治疗疑似及非疑似恶性肾上腺肿瘤的患者进行回顾性研究。如果患者有肾上腺外原发性恶性肿瘤病史和/或细针穿刺细胞学检查结果为阳性,则怀疑肾上腺肿块为转移瘤。如果细针穿刺细胞学检查结果为阳性和/或肾上腺影像学表现为恶性,则怀疑为原发性肾上腺癌。
(1)肿瘤切除边缘;(2)肿瘤复发(局部、切口部位和远处);(3)无病生存期。
23例患者(15例男性和8例女性)接受了24例腹腔镜手术(20例肾上腺切除术、3例活检和1例诊断性腹腔镜检查)。23例患者的永久性组织学标本显示5例肾上腺皮质癌、1例未分化肾上腺癌、13例肾上腺转移瘤、2例淋巴瘤和2例无肿瘤证据的病例。临床怀疑的肾上腺转移瘤在19例患者中为真阳性(83%)。细针穿刺细胞学检查的敏感性为57%(n = 7)。6例原发性肾上腺癌患者中只有1例术前被怀疑患有恶性肿瘤。所有肾上腺切除术的肿瘤切除边缘均为阴性。6例原发性肾上腺癌患者中有3例局部复发(2例局部复发和1例淋巴结转移),无切口部位复发,13例肾上腺转移瘤患者中有4例远处复发。平均随访3.3年(范围为1 - 7年)时,无病生存率为65%。
对于疑似肾上腺转移瘤的患者,腹腔镜手术兼具诊断和治疗作用,且能实现肿瘤的完整切除。相比之下,临床未怀疑的肾上腺皮质癌行腹腔镜肾上腺切除术的复发率较高。此外,术前细针穿刺细胞学检查用于评估疑似恶性肾上腺肿瘤并不可靠。